IHL - INCANNEX NEWS ARTICLES, page-254

View the Yahoo Finance Link here

View the Edison Group Research Report on Incannex here
https://www.edisongroup.com/publication/addressing-unmet-needs-via-alternative-approach/31265/
----------------------------
Interesting to note that the valuation is based on the US Market penetration alone and...
"We ascribe 92% of the company’s valuation to IHL-42X, 1% to psilocybin and 7% to cash.
We have not included the earlier-stage assets IHL-675A or IHL-216A in our valuation; however, we will revisit our valuation following clinical progression of these therapies."

---------------------------
GLAH (looking forward to Top 20 shareholder update)